Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Kogner

Showing results (71-80 of 168) with videos related to

Pageof 17
Sort By:
Frontiers in Oncology|May 19, 2025
Comparative analysis of whole-genome sequencing of tumor and cfDNA in a neuroblastoma patient: a case reportSusanne Fransson, Kleopatra Georgantzi, Anna Djos, et al.
International Journal of Cancer|December 6, 2008
Metronomic scheduling of imatinib abrogates clonogenicity of neuroblastoma cells and enhances their susceptibility to selected chemotherapeutic drugs in vitro and in vivoEbba Palmberg, John Inge Johnsen, Janna Paulsson, et al.
Diagnostics (Basel, Switzerland)|September 23, 2022
Multifocal Neuroblastoma and Central Hypoventilation in An Infant with Germline <i>ALK</i> F1174I MutationAnna Djos, Diana Treis, Susanne Fransson, et al.
Neuro-Oncology Advances|April 20, 2022
Filamin A increases aggressiveness of human neuroblastomaSashidar Bandaru, Bharat Prajapati, Prasanna Kumar Juvvuna, et al.
Cancers|February 13, 2019
SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells in VitroConny Tümmler, Gianina Dumitriu, Malin Wickström, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2010
High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onsetHelena Carén, Hanna Kryh, Maria Nethander, et al.
Scientific Reports|January 1, 2021
Whole-genome sequencing of recurrent neuroblastoma reveals somatic mutations that affect key players in cancer progression and telomere maintenanceSusanne Fransson, Angela Martinez-Monleon, Mathias Johansson, et al.
Cancer Cell International|April 16, 2011
A 6-gene signature identifies four molecular subgroups of neuroblastomaFrida Abel, Daniel Dalevi, Maria Nethander, et al.
Neuroendocrinology|February 28, 2002
Elevated expression of galanin receptors in childhood neuroblastic tumorsAlexandra Berger, Camilla Tuechler, Dietmar Almer, et al.
Plos One|January 26, 2012
Autocrine prostaglandin E2 signaling promotes tumor cell survival and proliferation in childhood neuroblastomaAgnes Rasmuson, Anna Kock, Ole Martin Fuskevåg, et al.
Pageof 17

Showing results (71-80 of 168) with videos related to

Sort By:
Pageof 17
Frontiers in Oncology|May 19, 2025
Comparative analysis of whole-genome sequencing of tumor and cfDNA in a neuroblastoma patient: a case reportSusanne Fransson, Kleopatra Georgantzi, Anna Djos, et al.
International Journal of Cancer|December 6, 2008
Metronomic scheduling of imatinib abrogates clonogenicity of neuroblastoma cells and enhances their susceptibility to selected chemotherapeutic drugs in vitro and in vivoEbba Palmberg, John Inge Johnsen, Janna Paulsson, et al.
Diagnostics (Basel, Switzerland)|September 23, 2022
Multifocal Neuroblastoma and Central Hypoventilation in An Infant with Germline <i>ALK</i> F1174I MutationAnna Djos, Diana Treis, Susanne Fransson, et al.
Neuro-Oncology Advances|April 20, 2022
Filamin A increases aggressiveness of human neuroblastomaSashidar Bandaru, Bharat Prajapati, Prasanna Kumar Juvvuna, et al.
Cancers|February 13, 2019
SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells in VitroConny Tümmler, Gianina Dumitriu, Malin Wickström, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 11, 2010
High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onsetHelena Carén, Hanna Kryh, Maria Nethander, et al.
Scientific Reports|January 1, 2021
Whole-genome sequencing of recurrent neuroblastoma reveals somatic mutations that affect key players in cancer progression and telomere maintenanceSusanne Fransson, Angela Martinez-Monleon, Mathias Johansson, et al.
Cancer Cell International|April 16, 2011
A 6-gene signature identifies four molecular subgroups of neuroblastomaFrida Abel, Daniel Dalevi, Maria Nethander, et al.
Neuroendocrinology|February 28, 2002
Elevated expression of galanin receptors in childhood neuroblastic tumorsAlexandra Berger, Camilla Tuechler, Dietmar Almer, et al.
Plos One|January 26, 2012
Autocrine prostaglandin E2 signaling promotes tumor cell survival and proliferation in childhood neuroblastomaAgnes Rasmuson, Anna Kock, Ole Martin Fuskevåg, et al.
Pageof 17